Contract Research Organization Market is Poised to Reach USD 122.2 Billion by 2032 | SkyQuest Technology Consulting

The pharmaceutical industry's increasing focus on creating novel medications to treat a variety of chronic illnesses is the main factor propelling the expansion of the contract research organization sector. 

WESTFORD, Mass., July 31, 2025 /PRNewswire/ -- SkyQuest Technology Consulting published a report, titled, Contract Research Organization Market - Global Opportunity Analysis and Industry Forecast, 2025-2032", valued at USD 64.6 Billion in 2024. With a projected CAGR of 8.3% from 2025 to 2032, the market is expected to reach USD 122.2 Billion by the end of 2032. The increasing number of clinical trials conducted globally is the main factor propelling the growth of the contract research organization sector over the forecast period. Pharmaceutical companies' greater emphasis on research and development (R&D) activities to produce new products will be advantageous to the CRO sector. Globally, about one in three adults suffers from multiple chronic illnesses. The need for effective treatments is growing along with the number of chronic illnesses, which motivates pharmaceutical and biotechnology companies to develop new drugs.

Download Sample Pages of the Report: https://www.skyquestt.com/sample-request/contract-research-organization-market

Contract Research Organization Market Key Growth Drivers

Over the years, pharmaceutical and biotechnology companies have increasingly used CROs in R&D due to their cost-effectiveness and efficiency. This would allow companies to leverage the specialized knowledge offered by other organizations while focusing their internal workforce or resources on core competencies. The need for effective solutions is being fuelled by demands for increasingly affordable products in the drug development industry.

Moreover, two new growth opportunities in the contract research organization (CRO) market are the increasing demand for gene therapies and personalized medicine. These novel treatments would necessitate specialized clinical trials and regulatory knowledge, which might present CROs with chances to expand their product lines in the development of sophisticated therapies.

Recent Developments in Contract Research Organization Market

• In March 2024, Heeds, a European contract research organization was acquired. Veeda Clinical Research Ltd., a leading CRO based in India was behind this acquisition as it focuses on expanding its business scope and operations to new regions.
• In July 2024, IQVIA, a well-known company in the global contract research organization landscape, announced the release of new technology to improve business operations. One Home for Sites brings together all of the systems at a clinical trial site into one, easy-to-use dashboard.
• In September 2024, A new contract research organization solution for ophthalmology clinical trials was launched by Lindus Health. The new solution can handle vast amounts of data generated from clinical trials to enhance the operation of contract research organizations compared to the traditional approach.

Speak to our Analyst: https://www.skyquestt.com/speak-with-analyst/contract-research-organization-market

Schreibe Deinen Kommentar